Crossmark

Circulating miR-141 and miR-375 are associated with treatment outcome in metastatic castration resistant prostate cancer

Crossref DOI link: https://doi.org/10.1038/s41598-019-57101-7

Published Online: 2020-01-14

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Zedan, A. H. https://orcid.org/0000-0002-8895-6394
Osther, P. J. S.

Assenholt, J.

Madsen, J. S. https://orcid.org/0000-0001-6668-4714
Hansen, T. F.
License Information

Text and Data Mining valid from 2020-01-14

Version of Record valid from 2020-01-14
More Information

Article History

Received: 3 July 2019

Accepted: 20 December 2019

First Online: 14 January 2020

Competing interests

: The authors declare no competing interests.